153 related articles for article (PubMed ID: 30290717)
21. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
23. A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus.
Wang D; Zhang H; Liang J; Wang H; Hua B; Feng X; Gilkeson GS; Farge D; Shi S; Sun L
Stem Cell Reports; 2018 Mar; 10(3):933-941. PubMed ID: 29478901
[TBL] [Abstract][Full Text] [Related]
24. Commentary on the Current Guidelines for the Diagnosis of Lupus Nephritis Flare.
Ayoub I; Birmingham D; Rovin B; Hebert L
Curr Rheumatol Rep; 2019 Feb; 21(4):12. PubMed ID: 30810824
[TBL] [Abstract][Full Text] [Related]
25. Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare.
Singh RG; Usha ; Rathore SS; Behura SK; Singh NK
Lupus; 2012 Oct; 21(11):1214-8. PubMed ID: 22759858
[TBL] [Abstract][Full Text] [Related]
26. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
[TBL] [Abstract][Full Text] [Related]
27. Renal biopsy in the management of lupus nephritis during pregnancy.
Chen TK; Gelber AC; Witter FR; Petri M; Fine DM
Lupus; 2015 Feb; 24(2):147-54. PubMed ID: 25249595
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stem cell therapy induces FLT3L and CD1c
Yuan X; Qin X; Wang D; Zhang Z; Tang X; Gao X; Chen W; Sun L
Nat Commun; 2019 Jun; 10(1):2498. PubMed ID: 31175312
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis.
Chang JW; Hung SP; Wu HH; Wu WM; Yang AH; Tsai HL; Yang LY; Lee OK
Cell Transplant; 2011; 20(2):245-57. PubMed ID: 20719085
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder.
Fathollahi A; Gabalou NB; Aslani S
Lupus; 2018 Jun; 27(7):1053-1064. PubMed ID: 29631514
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum levels of syndecan-1 are associated with renal involvement in patients with systemic lupus erythematosus.
Kim KJ; Kim JY; Baek IW; Kim WU; Cho CS
J Rheumatol; 2015 Feb; 42(2):202-9. PubMed ID: 25512478
[TBL] [Abstract][Full Text] [Related]
32. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
[TBL] [Abstract][Full Text] [Related]
33. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
[TBL] [Abstract][Full Text] [Related]
34. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
[TBL] [Abstract][Full Text] [Related]
35. Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.
Brugos B; Kiss E; Dul C; Gubisch W; Szegedi G; Sipka S; Zeher M
Hum Immunol; 2010 Sep; 71(9):874-7. PubMed ID: 20538031
[TBL] [Abstract][Full Text] [Related]
36. Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity.
Stummvoll GH; Schmaldienst S; Smolen JS; Derfler K; Biesenbach P
Nephrol Dial Transplant; 2012 Feb; 27(2):618-26. PubMed ID: 21617196
[TBL] [Abstract][Full Text] [Related]
37. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
38. Stem cells for lupus nephritis: a concise review of current knowledge.
Sattwika PD; Mustafa R; Paramaiswari A; Herningtyas EH
Lupus; 2018 Oct; 27(12):1881-1897. PubMed ID: 30099942
[TBL] [Abstract][Full Text] [Related]
39. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
Tripathy R; Panda AK; Das BK
Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.
Terrier B; Amoura Z; Ravaud P; Hachulla E; Jouenne R; Combe B; Bonnet C; Cacoub P; Cantagrel A; de Bandt M; Fain O; Fautrel B; Gaudin P; Godeau B; Harlé JR; Hot A; Kahn JE; Lambotte O; Larroche C; Léone J; Meyer O; Pallot-Prades B; Pertuiset E; Quartier P; Schaerverbeke T; Sibilia J; Somogyi A; Soubrier M; Vignon E; Bader-Meunier B; Mariette X; Gottenberg JE;
Arthritis Rheum; 2010 Aug; 62(8):2458-66. PubMed ID: 20506527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
